Cargando…

Insulin-Based Versus Triple Oral Therapy for Newly Diagnosed Type 2 Diabetes: Which is better?

OBJECTIVE: Early use of insulin after diagnosis of type 2 diabetes is met with resistance because of associated weight gain, hypoglycemia, and fear of decreased compliance and quality of life (QoL). RESEARCH DESIGN AND METHODS: In treatment-naive patients with newly diagnosed type 2 diabetes, insuli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lingvay, Ildiko, Legendre, Jaime L., Kaloyanova, Polina F., Zhang, Song, Adams-Huet, Beverley, Raskin, Philip
Formato:	Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2009
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2752924/ https://www.ncbi.nlm.nih.gov/pubmed/19592630 http://dx.doi.org/10.2337/dc09-0653

Ejemplares similares

β-Cell Function Preservation After 3.5 Years of Intensive Diabetes Therapy
por: Harrison, Lindsay B., et al.
Publicado: (2012)

Comparative Evaluation of Two Venous Sampling Techniques for the Assessment of Pancreatic Insulin and Zinc Release upon Glucose Challenge
por: Pillai, Anil Kumar, et al.
Publicado: (2015)

Effect of medication adherence on clinical outcomes in type 2 diabetes: analysis of the SIMPLE study
por: Patel, Sapna, et al.
Publicado: (2019)

Response to Comment on: Harrison et al. β-Cell Function Preservation After 3.5 Years of Intensive Diabetes Therapy. Diabetes Care 2012;35:1406–1412
por: Harrison, Lindsay B., et al.
Publicado: (2013)

Correlates of Insulin Resistance in Nascent Metabolic Syndrome
por: Adams-Huet, Beverley, et al.
Publicado: (2023)

Which Needle Is Better for Diagnosing Subepithelial Lesions?
por: Kim, Eun Young
Publicado: (2015)

Real-world clinical outcomes following treatment intensification with GLP-1 RA, OADs or insulin in patients with type 2 diabetes on two oral agents (PATHWAY 2-OADs)
por: Desouza, Cyrus, et al.
Publicado: (2020)

Efficacy and Safety of Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in High-Risk and Low-Risk Patients with Type 2 Diabetes Stratified Using Common Clinical Performance Measures
por: Lingvay, Ildiko, et al.
Publicado: (2017)

Different Gestational Diabetes Phenotypes: Which Insulin Regimen Fits Better?
por: Mecacci, Federico, et al.
Publicado: (2021)

Insulin Oedema in Newly Diagnosed Type 1 Diabetes Mellitus
por: Baş, Veysel Nijat, et al.
Publicado: (2010)

Rates of hypoglycaemia are lower in patients treated with insulin degludec/liraglutide (IDegLira) than with IDeg or insulin glargine, regardless of the hypoglycaemia definition used
por: Norwood, Paul, et al.
Publicado: (2017)

An Indirect Comparison of Basal Insulin Plus Once-Weekly Semaglutide and Fully Optimised Basal–Bolus Insulin in Type 2 Diabetes
por: Lingvay, Ildiko, et al.
Publicado: (2022)

Abstract 3: CGM-derived parameters for once-weekly insulin icodec versus once-daily insulin glargine U100 in insulin-Naïve patients with T2D
por: Kunder, Sushil, et al.
Publicado: (2022)

Clinical characteristics and factors associated with triple therapy use in newly diagnosed patients with COPD
por: Monteagudo, Mònica, et al.
Publicado: (2021)

Switching Between Glucagon-Like Peptide-1 Receptor Agonists: Rationale and Practical Guidance
por: Almandoz, Jaime P., et al.
Publicado: (2020)

Which Color Channel Is Better for Diagnosing Retinal Diseases Automatically in Color Fundus Photographs?
por: Biswas, Sangeeta, et al.
Publicado: (2022)

Efficacy and safety of ertugliflozin in patients with type 2 diabetes mellitus and established cardiovascular disease using insulin: A VERTIS CV substudy
por: Lingvay, Ildiko, et al.
Publicado: (2021)

Leptin in Children with Newly Diagnosed Type 1 Diabetes: Effect of Insulin Therapy
por: McCormick, Kenneth L., et al.
Publicado: (2001)

Anasarca in Newly Diagnosed Type 1 Diabetes: Review of the Pathophysiology of Insulin Edema
por: Wong, Marc, et al.
Publicado: (2020)

Which sample type is better for Xpert MTB/RIF to diagnose adult and pediatric pulmonary tuberculosis?
por: Lyu, Mengyuan, et al.
Publicado: (2020)

Ultrasound vs. clinical diagnosis—which is better in diagnosing acute appendicitis?: a cohort study
por: Kam, Cheuk Tung, et al.
Publicado: (2023)

A Randomized Trial of Insulin Glargine plus Oral Hypoglycemic Agents versus Continuous Subcutaneous Insulin Infusion to Treat Newly Diagnosed Type 2 Diabetes
por: Lin, Shuo, et al.
Publicado: (2018)

Insulin degludec/liraglutide (IDegLira) was effective across a range of dysglycaemia and body mass index categories in the DUAL V randomized trial
por: Lingvay, Ildiko, et al.
Publicado: (2017)

Insights into the early use of oral semaglutide in routine clinical practice: The IGNITE study
por: Aroda, Vanita R., et al.
Publicado: (2021)

Development of Exogenous Insulin Antibody Syndrome in a Patient with Newly Diagnosed Type 1 Diabetes Successfully Treated with Oral Immunosuppressive Monotherapy
por: Jerkins, Terri, et al.
Publicado: (2021)

Efficacy, safety and cost-effectiveness comparison between U-100 human regular insulin and rapid acting insulin when delivered by V-Go wearable insulin delivery device in type 2 diabetes
por: Mora, Pablo F, et al.
Publicado: (2020)

A Randomized, Open-Label Comparison of Once-Weekly Insulin Icodec Titration Strategies Versus Once-Daily Insulin Glargine U100
por: Lingvay, Ildiko, et al.
Publicado: (2021)

Evaluating computing students' digital skills and health literacy: A case from Bulgaria
por: Kaloyanova, Kalinka, et al.
Publicado: (2023)

Survival, treatment regimens and medical costs of women newly diagnosed with metastatic triple-negative breast cancer
por: Hsu, Ju-Yi, et al.
Publicado: (2022)

Economic evaluation of infliximab, synthetic triple therapy and methotrexate in the treatment of newly diagnosed juvenile idiopathic arthritis
por: Tarkiainen, Maarit, et al.
Publicado: (2022)

The Initial Assessment of Daily Insulin Dose in Chinese Newly Diagnosed Type 2 Diabetes
por: Ma, Jing, et al.
Publicado: (2016)

Insulin Independence in Newly Diagnosed Type 1 Diabetes Patient following Fenofibrate Treatment
por: Buschard, Karsten, et al.
Publicado: (2020)

Oral ixazomib, lenalidomide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myeloma
por: Facon, Thierry, et al.
Publicado: (2021)

Comparison between newly diagnosed hypertension in diabetes and newly diagnosed diabetes in hypertension
por: Liu, Chang-Yuan, et al.
Publicado: (2019)

OR30-02 Efficacy and Safety Comparison Between U100 Regular Human Insulin and U100 Rapid Acting Insulin When Delivered by a 24 Hour Wearable Insulin Delivery Device in Type 2 Diabetes
por: Mora, Pablo, et al.
Publicado: (2020)

Insulin resistance and beta‐cell dysfunction in newly diagnosed type 2 diabetes: Expression, aggregation and predominance. Verona Newly Diagnosed Type 2 Diabetes Study 10
por: Bonora, Enzo, et al.
Publicado: (2022)

Changing Clinical Characteristics according to Insulin Resistance and Insulin Secretion in Newly Diagnosed Type 2 Diabetic Patients in Korea
por: Son, Jang Won, et al.
Publicado: (2015)

Which one is better, Wallace or Bricker?
por: Khurana, Naval, et al.
Publicado: (2007)

Metabolic syndrome remission after Roux-en-Y gastric bypass or sleeve gastrectomy
por: Nassour, Ibrahim, et al.
Publicado: (2017)

Which quantitative perfusion estimation model is better at diagnosing myocardial ischaemia? A CE-MARC sub-study
por: Biglands, John D, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_572d9mt58b062jnpg4no97kdrd